Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 29.24
-0.34 (-1.15%)
Mar 30, 2026, 3:00 PM CST
SHA:688639 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 132.41 | 189.52 | 449.06 | 320.03 | 168.24 |
Depreciation & Amortization | 214.8 | 138.66 | 98.84 | 59.15 | 47.5 |
Other Amortization | 6.24 | 0.93 | - | - | - |
Loss (Gain) From Sale of Assets | -0.12 | 0.06 | 0.01 | -0.02 | 0.07 |
Asset Writedown & Restructuring Costs | 1.86 | 0.31 | 2.66 | 4.29 | 6.1 |
Loss (Gain) From Sale of Investments | 0.92 | -0.85 | -2.55 | -7.49 | -6.55 |
Provision & Write-off of Bad Debts | -0.65 | -1.22 | 0.4 | 2.5 | -0.48 |
Other Operating Activities | 48.91 | 24.21 | 4.58 | -0.84 | 1.7 |
Change in Accounts Receivable | -73.48 | -58.42 | -89.7 | -102.17 | -138.58 |
Change in Inventory | -138.94 | -181.1 | -173.52 | -35.85 | -76.72 |
Change in Accounts Payable | -66.78 | 85.66 | -18.08 | 75.28 | 84.64 |
Change in Other Net Operating Assets | 3.88 | 8.75 | 21.04 | 36.43 | 2.25 |
Operating Cash Flow | 104.55 | 199.79 | 301.42 | 357.43 | 95.7 |
Operating Cash Flow Growth | -47.67% | -33.72% | -15.67% | 273.48% | -12.65% |
Capital Expenditures | -636.73 | -923.51 | -1,269 | -456.35 | -180.63 |
Sale of Property, Plant & Equipment | 1.19 | 0.37 | 6.59 | 0.26 | 1.34 |
Cash Acquisitions | - | - | - | -4.69 | - |
Investment in Securities | -2.82 | -10.2 | 127.6 | 107 | -345 |
Other Investing Activities | -5.1 | 3.25 | 7.92 | 11.77 | 12.47 |
Investing Cash Flow | -643.46 | -930.09 | -1,127 | -342 | -511.82 |
Short-Term Debt Issued | - | - | - | - | 53.77 |
Long-Term Debt Issued | 1,718 | 1,761 | 1,412 | 111.78 | - |
Total Debt Issued | 1,718 | 1,761 | 1,412 | 111.78 | 53.77 |
Short-Term Debt Repaid | - | - | - | - | -90 |
Long-Term Debt Repaid | -1,187 | -1,471 | -246.34 | -51.06 | - |
Total Debt Repaid | -1,187 | -1,471 | -246.34 | -51.06 | -90 |
Net Debt Issued (Repaid) | 530.99 | 289.66 | 1,166 | 60.72 | -36.23 |
Issuance of Common Stock | 5.08 | 689.13 | 7.09 | 6 | 595.97 |
Repurchase of Common Stock | - | -11.97 | -38.04 | - | - |
Common Dividends Paid | -110.81 | -183.41 | -108.89 | -60.26 | -37.56 |
Dividends Paid | -110.81 | -183.41 | -108.89 | -60.26 | -37.56 |
Other Financing Activities | -16.03 | -2.66 | -1.54 | - | -45.2 |
Financing Cash Flow | 409.22 | 780.75 | 1,025 | 6.46 | 476.98 |
Foreign Exchange Rate Adjustments | -1.15 | 12.02 | 6.54 | 5.25 | -0.69 |
Net Cash Flow | -130.84 | 62.47 | 205.52 | 27.13 | 60.17 |
Free Cash Flow | -532.18 | -723.72 | -967.75 | -98.92 | -84.93 |
Free Cash Flow Margin | -18.60% | -33.23% | -49.93% | -6.97% | -8.90% |
Free Cash Flow Per Share | -2.13 | -3.13 | -4.22 | -0.43 | -0.41 |
Cash Income Tax Paid | -32.02 | -0.45 | 11.44 | -2.62 | -0.92 |
Levered Free Cash Flow | -434.99 | -939.38 | -602.11 | -143.41 | -158.36 |
Unlevered Free Cash Flow | -407.6 | -915.71 | -595.46 | -143.08 | -157.66 |
Change in Working Capital | -299.82 | -151.82 | -251.58 | -20.2 | -120.88 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.